|
Bonanad Lozano C, Diez-Villanueva P, Blas SG, Ayesta A, Ibars S, Ariza-Sole A, Ferreiro JL, Moreno R, Roldan I, Marin F, Carol Ruiz A, Garcia Pardo H, Sanchis J, Cruz-Gonzalez I, Anguita M, Cequier A, Ruiz Garcia J, Martinez-Selles M. [Impact of antithrombotic treatment and geriatric syndromes in octogenarians with atrial fibrillation and ischaemic heart disease. Atrial Fibrillation and Ischemic Heart Disease in the Elderly]. Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):338-342. doi: 10.1016/j.regg.2020.05.008. Epub 2020 Jul 25. Spanish. PubMed PMID: 32718577.
AÑO: 2020
|
32718577
|
Ruiz-Sanchez JG, Nunez-Gil IJ, Cuesta M, Rubio MA, Maroun-Eid C, Arroyo-Espliguero R, Romero R, Becerra-Munoz VM, Uribarri A, Feltes G, Trabattoni D, Molina M, Garcia Aguado M, Pepe M, Cerrato E, Alfonso E, Castro Mejia AF, Roubin SR, Buzon L, Bondia E, Marin F, Lopez Pais J, Abumayyaleh M, D'Ascenzo F, Rondano E, Huang J, Fernandez-Perez C, Macaya C, de Miguel Novoa P, Calle-Pascual AL, Estrada Perez V, Runkle I; HOPE COVID-19 investigators. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. Front Endocrinol (Lausanne). 2020 Nov 30;11:599255. doi: 10.3389/fendo.2020.599255. eCollection 2020. PubMed PMID: 33329400; PubMed Central PMCID: PMC7734292.
AÑO: 2020; IF: 5.555
|
|
Perez-Andreu J, Arribas Leal JM, Gervase G, Rivera-Caravaca JM, Canovas Lopez S, Marin F. Epidemiology of Cardiac Myxoma in a Spanish Population. A 30-year Surgical Series. Rev Esp Cardiol (Engl Ed). 2019 Aug;72(8):685-686. doi: 10.1016/j.rec.2018.08.021. Epub 2018 Oct 11. No abstract available. English, Spanish. PubMed PMID: 30316755.
AÑO: 2019; IF: 4.642
|
|
Rivera-Caravaca JM, Marin F, Vilchez JA, Galvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldan V. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. Stroke. 2019 Jun;50(6):1372-1379. doi: 10.1161/STROKEAHA.118.024305. Epub 2019 May 14. PubMed PMID: 31084333.
AÑO: 2019; IF: 10.17
|
|
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tunon J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum In: Lancet Diabetes Endocrinol. 2019 Jul 8;: Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21. PubMed PMID: 31272931.
AÑO: 2019; IF: 25.34
|